Dr Rhonda LaFleur | Principal Scientist
Merck Animal Health

Dr Rhonda LaFleur, Principal Scientist, Merck Animal Health

  • 1992:  received Bachelor of Science degree from University of Nebraska - Lincoln
  • 1998:  received PhD in Molecular Veterinary Biosciences from University of Minnesota
  • 1998 to present:  leads a team of researchers at Merck Animal Health that develops new or improved vaccines for companion animals


DC Co-conference Day 2 April 4 @ 5:40

Nobivac® canine flu bivalent vaccine

  • Merck Animal Health’s response to CIV H3N2 outbreak in Chicago
  • CIV H3N2 infection in dogs
  • First vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8
  • Efficacy study results
  • Next steps

back to speakers